Tumor size limits macrophage activation and imaging response to CD47 blockade in osteosarcoma
{{output}}
Despite robust preclinical activity, CD47-targeting agents demonstrate limited single-agent efficacy in osteosarcomas. The purpose of our study was to investigate whether tumor size at baseline affects tumor-associated macrophage (TAM) response to CD47 mAb, as... ...
